LALPATHLAB

Dr. Lal Path Labs Ltd

Healthcare

Share price

₹1,964

Market cap

₹32,914 Cr

1Y return

▲ 25%

A leading diagnostic services provider in India, Dr. Lal PathLabs operates an integrated nationwide network delivering laboratory tests and comprehensive healthcare services. The company serves individual patients, hospitals, healthcare providers, and corporate clients through core diagnostic testing, disease diagnosis, prevention, monitoring, and treatment support. Its distinctive strength lies in combining consumer accessibility with a broad range of diagnostic capabilities and related health services across the country.

Investors holding Dr. Lal Path Labs Ltd

American Funds (Capital Group)

Foreign Investor

1.98%

Institution

1.47%

Tata Mutual Fund

Mutual Fund

1.41%

Foreign Investor

1.37%

Recent moves 8

Tata Mutual FundDecreased

Tata Mutual Fund sold 5,66,848 shares of Dr. Lal Path Labs Ltd, reducing its stake from 1.75% to 1.41% for approximately ₹108.21 Cr at ₹1,909 apiece.

SBI Mutual FundExited

SBI Mutual Fund is no longer on Dr. Lal Path Labs Ltd's list of disclosed shareholders, after its last reported stake of 1.65 percent, indicating either a complete sale or a reduction below the 1 percent disclosure threshold.

23 Jul 2026. Sign in to see this move

American Funds (Capital Group)Increased

American Funds (Capital Group) increased its stake in Dr. Lal Path Labs Ltd from 1.42% to 1.98%, buying 946,108 shares worth ₹160.74 Cr.

UTI Mutual FundIncreased

UTI Mutual Fund increased its stake in Dr. Lal Path Labs to 2.64% from 2.52%, increasing its shareholding from 4,223,290 to 4,430,364 shares. The value of the additional 207,074 shares was approximately ₹35.18 Cr based on the share price of ₹1699.00.

Aditya Birla Sun Life Mutual FundIncreased

Aditya Birla Sun Life Mutual Fund increased its stake in Dr. Lal Path Labs Ltd from 1.41% to 1.78% by purchasing 6,16,676 shares. The value of these shares is ₹104.77 Cr at a price of ₹1699.00 apiece.

Nippon India Mutual FundIncreased

Nippon India Mutual Fund increased its stake in Dr. Lal Path Labs Ltd from 2.42% to 2.63%, raising its shareholding from 4,046,700 to 4,415,617 shares. The additional 368,917 shares are valued at ₹62.68 crore based on the closing price of ₹1699.00 per share.

HDFC Mutual FundDecreased

HDFC Mutual Fund decreased its stake in Dr. Lal Path Labs from 4.05% to 3.91%, selling 233,290 shares. At a share price of ₹1699.00, the sale was worth approximately ₹39.64 Cr.

Track the whales in Dr. Lal Path Labs Ltd

Get alerted the moment a top investor buys or sells.